Repeated administration of bone marrow-derived cells prevents disease progression in experimental silicosis

Cellular Physiology and Biochemistry

Volumn 32, Issue 6, 2013, Pages 1681-1694

  Lopes Pacheco, Miquéias ^a   Xisto, Debora G ^a   Ornellas, Felipe M ^a   Antunes, Mariana A ^a   Abreu, Soraia C ^a   Rocco, Patricia R M ^a   Takiya, Christina M ^a   Morales, Marcelo M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cell therapy; Elastic fiber; Fibrosis; Inflammation; Silicosis

Indexed keywords

CASPASE 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; GELATINASE B; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED CELL; CELL THERAPY; CONTROLLED STUDY; DISEASE COURSE; ELASTIC FIBER; FEMALE; GRANULOMA; HISTOLOGY; INFLAMMATION; LUNG MECHANICS; LUNG PARENCHYMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SILICOSIS; Y CHROMOSOME; CELL COUNT; CELL INFILTRATION; DOWN REGULATION; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REPEAT PROCEDURE; REPEATED DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; WOUND HEALING;

MURINAE; MUS;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CASPASE 3; COLLAGEN TYPE I; COLLAGEN TYPE III; CYTOKINES; DISEASE PROGRESSION; FEMALE; GRANULOMA; LUNG; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; RNA, MESSENGER; SILICON DIOXIDE; SILICOSIS;

EID: 84890452149     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356603     Document Type: Article

References (37)

1. Srivastava KD, Rom WN, Jagirdar J, Yie TA, Gordon T, Tchou-Wong KM: Crucial role of interleukin-lbeta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med 2002;165:527-533.
2. Huaux F: New developments in the understanding of immunology in silicosis. Curr Opin Allery Clin Immunol 2007;7:168-173.
3. Maron-Gutierrez T, Castiglione RC, Xisto DG, Oliveira MG, Cruz FF, Pefanha R, Carreira-Junior H, Ornellas DS, Moraes MO, Takiya CM, Rocco PR, Morales MM: Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. Eur Respir J2011;37:1217-1225.
4. Leung CC, Yu IT, Chen W: Silicosis. Lancet2012;379:2008-2018.
5. Abreu SC, Antunes MA, Pelosi P, Morales MM, Rocco PR: Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med 2011;37:1421-1431.
6. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152.
7. Spees JL, Pociask DA, Sullivan DE, Whitney ML, Lasky JA, Prockop DJ, Brody AR: Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis. Am J Respir Crit Care Med 2007;176:385-394.
8. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A: Bone marrow-derived cells as progenitors oflung alveolar epithelium. Development 2001;28:5181-5188.
9. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG: Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad SciUSA 2007;104:11002-11007.
10. Cruz FF, Antunes MA, Abreu SC, Fujisaki LC, Silva JD, Xisto DG, Maron-Gutierrez T, Ornellas DS, Sa VK, Rocha NN, Capelozzi VL, Morales MM, Rocco PR: Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model. Respir Physiol Neurobiol 2012;182:26-36.
11. Lassance RM, Prota LF, Maron-Gutierrez T, Garcia CS, Abreu SC, Passaro CP, Xisto DG, Castiglione RC, Carreira H Jr, Ornellas DS, Santana MC, Souza SA, Gulfillen B, Fonseca LM, Rocco PR, Morales MM: Intratracheal instillation ofbone marrow-derived cell in an experimental model of silicosis. Respir Physiol Neurobiol 2009;169:227-233.
12. Bates JH, Decramer M, Chartrand D, Zin WA, BoddenerA, Milic-Emili J: Volume-time profile during relaxed expiration inthe normal dog. J Appl Physiol 1985;59:732-737.
13. Weibel ER: Morphometry: stereological theory and practical methods; in Gil J (ed): Models of Lung Disease Microscopy and Structural Methods. NewYork, Marcel Dekker, 1990, pp 199-247.
14. Faffe DS, Silva GH, Kurtz PM, Negri EM, Capelozzi VL, Rocco PR, Zin WA: Lung tissue mechanics and extracellular matrix composition in a murine model of silicosis. J Appl Physiol 2001;90:1400-1406.
15. Borges VM, Falcao H, Leite-Junior JH, Alvim L, Teixeira GP, Russo M, Nobrega AF, Lopes MF, Rocco PM, Davidson WF, Linden R, Yagita H, Zin WA, DosReis GA: Fas ligand triggers pulmonary silicosis. J Exp Med 2001;194:155-164.
16. Borges VM, Lopes MF, Falcao H, Leite-Junior H, Rocco PR, Davidson WF, Linden R, Zin WA, DosReis GA: Apoptosis underlies immunopathogenic mechanisms in acute silicosis. Am J Respir Cell Mol Biol 2002;27:78-84.
17. Rimal B, Greenberg AK, Rom WN: Basic pathogenetic mechanisms on silicosis: currentunderstanding. Curr Opin Pulm Med 2005;11:169-173.
18. Greenberg MI, Waksman J, Curtis J: Silicosis: a review. Dis Mon 2007;53:394-416.
19. Arend WP, Gabay C: Physiologic role of interleukin-1 receptor antagonist. Arthritis Res 2000;2:245-248.
20. Levis J, Loi R, Butnor KJ, Vacek P, Steele C, Mossman BT, Weiss DJ: Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am J Respir Cell Mol Biol 2008;38:16-25.
21. Huaux F, Louahed J, Hudspith B, Meredith C, Delos M, Renauld JC, Lison D: Role of interleukin-10 inthe lung response to silica in mice. Am J Respir Mol Biol 1998;18:51-59.
22. Barbarin V, Arras M, Misson P, Delos M, McGarry B, Phan SH, Lison D, Huaux F: Characterization of the effect of interleukin-10 on silica-induced lung fibrosis in mice. Am J Respir Cell Mol Biol 2004;31:78-85.
23. Ishihara Y, Nishikawa T, Iijima H, Matsunaga K: Expression of matrix metalloproteinase, tissue inhibitor of metalloproteinase and adhesion molecules in silicotic mice with tumor metastasis. Toxicol Lett 2003;142:71-75.
24. Scabilloni JF, Wang L, Antonini JM, Roberts JR, Castranova V, Mercer RR: Matrix metalloproteinase induction in fibrosis and fibrotic nodules formation due to silica inhalation. Am J Physiol Lung Cell Mol Physiol 2005;288:L709-L717.
25. Lalmanach G, Diot E, Godat E, Lecaille F, Herve-GrepinetV: Cysteine cathepsins and caspases in silicosis. Biol Chem 2006;387:867-870.
26. Shen HM, Zhang Z, Zhang QF, Ong CN: Reactive oxygen species and caspase activation mediate silica- induced apoptosis in alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2001;280:L10-L17.
27. Sheng QS, Chen WB, Lin JJ, Liu FL, Chen DZ: Effects of autologous bone marrow mononuclear cells implantation on cholangiocytes apoptosis in model of intrahepatic ischemic type biliary lesion in rabbits. Transplant Proc 2012;44:1435-1438.
28. Mo SJ, Zhong Q, Zhou YF, Deng DB, Zhang XQ: Bone marrow-derived mesenchymal stem cells prevent the apoptosis of neuron-like PC12 cells via erythropoietin expression. Neurosci Lett 2012;522:92-97.
29. Rosenberg S, Zhang H, Zhang J: FADD deficiency impairs earlyhematopoiesis inthe bone marrow. J Immunol 2012;186:203-213.
30. Kanazawa H, Fujimoto Y, Teratani T, Iwasaki J, Kasahara N, Negishi K, Tsuruyama T, Uemoto S, Kobayashi E: Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS One 2011;6:el9195.
31. Lovell MJ, Yasin M, Lee KL, Cheung KK, Shintani Y, Leung KY, Takahashi K, Kapoor A, Yagoob MM, Suzuki K, Lythgoe MF, Martin J, Munroe PB, Thiemermann C, Mathur A: Bone marrow mononuclear cells reduce myocardial reperfusion injuryby activatingthe PI3K/Akt survival pathway. Atherosclerosis 2010;213:67-76.
32. Barreira AL, Takiya CM, Castiglione RC, Maron-Gutierrez T, Barbosa CM, Ornellas DS, Verdoorn KS, Pascarelli BM, Borojevic R, Einicker-Lamas M, Leite M Jr, Morales MM, Vieyra A: Bone marrow mononuclear cells attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells after unilateral ureteral obstruction. Cell Physiol Biochem 2009;24:585-594.
33. Mariani TJ, Roby JD, Mecham RP, Parks WC, Crouch E, Pierce RA: Localization of type I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor- beta as a mediator of fibrosis. Am J Pathol 1996;148:151-164.
34. Rahimi RA, LeofEB: TGF-beta signaling: atale oftwo responses. J Cell Biochem 2007;102: 591-608.
35. Mariani TJ, Crouch E, Roby JD, Starcher B, Pierce RA: Increased elastin production in experimental granulomatous lung disease. Am J Pathol 1995;147:988-1000.
36. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, KeatingA, Prockop DJ, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
37. Da Silva Meireles L, Caplan Al, Nardi NB: In search ofthe invivo identifyof mesenchymal stem cells. Stem cells 2008;26:1307-1314.